Real-world detection of paramagnetic rim lesions and their association with disease burden in multiple sclerosis

IF 3 3区 医学 Q2 CLINICAL NEUROLOGY
Olavi Misin , Anni Piispanen , Markus Matilainen , Riitta Parkkola , Mikko Nyman , Teija Sainio , Jussi Hirvonen , Laura Airas
{"title":"Real-world detection of paramagnetic rim lesions and their association with disease burden in multiple sclerosis","authors":"Olavi Misin ,&nbsp;Anni Piispanen ,&nbsp;Markus Matilainen ,&nbsp;Riitta Parkkola ,&nbsp;Mikko Nyman ,&nbsp;Teija Sainio ,&nbsp;Jussi Hirvonen ,&nbsp;Laura Airas","doi":"10.1016/j.msard.2026.107012","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Paramagnetic rim lesions (PRLs) are an emerging MRI biomarker in multiple sclerosis (MS). On susceptibility-sensitive MRI, PRLs are characterized by a paramagnetic shift at the lesion rim corresponding to iron-laden macrophages and microglia, and PRL detection can hence be viewed as a proxy for lesion-associated smoldering inflammation in MS brain. The aim of this study was to identify PRLs in a standard university hospital setting to explore the associations between PRL burden and MS-related clinical and paraclinical parameters.</div></div><div><h3>Methods</h3><div>We retrospectively reviewed all 3T brain MRI studies performed as part of MS patient management at a tertiary university hospital in Finland between September 2021 and December 2023. PRLs were visually identified on filtered phase images from susceptibility-weighted imaging (SWI) sequences. Brain volumetric data were extracted from post-contrast 3D T1-weighted images using an automated quantification tool (cNeuro® cMRI). Clinical and laboratory variables were obtained by manual chart review from electronic medical records.</div></div><div><h3>Results</h3><div>The final cohort included 206 patients. 34% of patients had at least one PRL (the PRL1+ group). The median number of PRLs in the PRL1+ group was 2 and the maximum number was 11. Within the PRL1+ group, PRL count correlated positively with Expanded Disability Status Scale (EDSS), Multiple Sclerosis Severity Score (MSSS) and T2 lesion volume. Patients with PRLs had significantly smaller thalami compared to those without PRLs.</div></div><div><h3>Discussion</h3><div>Our real-world data reinforce evidence that PRLs are linked to more severe disease and demonstrate that PRL identification using manufacturer-reconstructed SWI filtered phase images provides a feasible imaging parameter to assess progression-associated pathology in MS in a standard clinical setting.</div></div>","PeriodicalId":18958,"journal":{"name":"Multiple sclerosis and related disorders","volume":"107 ","pages":"Article 107012"},"PeriodicalIF":3.0000,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Multiple sclerosis and related disorders","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2211034826000489","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/16 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Paramagnetic rim lesions (PRLs) are an emerging MRI biomarker in multiple sclerosis (MS). On susceptibility-sensitive MRI, PRLs are characterized by a paramagnetic shift at the lesion rim corresponding to iron-laden macrophages and microglia, and PRL detection can hence be viewed as a proxy for lesion-associated smoldering inflammation in MS brain. The aim of this study was to identify PRLs in a standard university hospital setting to explore the associations between PRL burden and MS-related clinical and paraclinical parameters.

Methods

We retrospectively reviewed all 3T brain MRI studies performed as part of MS patient management at a tertiary university hospital in Finland between September 2021 and December 2023. PRLs were visually identified on filtered phase images from susceptibility-weighted imaging (SWI) sequences. Brain volumetric data were extracted from post-contrast 3D T1-weighted images using an automated quantification tool (cNeuro® cMRI). Clinical and laboratory variables were obtained by manual chart review from electronic medical records.

Results

The final cohort included 206 patients. 34% of patients had at least one PRL (the PRL1+ group). The median number of PRLs in the PRL1+ group was 2 and the maximum number was 11. Within the PRL1+ group, PRL count correlated positively with Expanded Disability Status Scale (EDSS), Multiple Sclerosis Severity Score (MSSS) and T2 lesion volume. Patients with PRLs had significantly smaller thalami compared to those without PRLs.

Discussion

Our real-world data reinforce evidence that PRLs are linked to more severe disease and demonstrate that PRL identification using manufacturer-reconstructed SWI filtered phase images provides a feasible imaging parameter to assess progression-associated pathology in MS in a standard clinical setting.
多发性硬化症中顺磁边缘病变的真实世界检测及其与疾病负担的关系。
背景:顺磁边缘病变(prl)是多发性硬化症(MS)的一种新兴MRI生物标志物。在敏感MRI上,PRL的特征是病变边缘的顺磁移位,与铁负载巨噬细胞和小胶质细胞相对应,因此PRL的检测可以被视为MS脑病变相关的阴燃炎症的代理。本研究的目的是在一个标准的大学医院环境中识别PRL,探讨PRL负担与ms相关的临床和临床参数之间的关系。方法:我们回顾性回顾了2021年9月至2023年12月期间芬兰一家三级大学医院作为MS患者管理一部分进行的所有3T脑MRI研究。利用加权成像(SWI)序列滤波后的相位图像进行prl的视觉识别。使用自动量化工具(cNeuro®cMRI)从对比后的3D t1加权图像中提取脑容量数据。临床和实验室变量通过手工图表审查电子病历获得。结果:最终队列包括206例患者。34%的患者至少有一个PRL (PRL1+组)。PRL1+组prl中位数为2个,最大值为11个。在PRL1+组中,PRL计数与扩展残疾状态量表(EDSS)、多发性硬化严重程度评分(MSSS)和T2病变体积呈正相关。与没有prl的患者相比,prl患者的丘脑明显更小。讨论:我们的真实世界数据强化了PRL与更严重疾病相关的证据,并证明使用制造商重建的SWI滤波相位图像识别PRL为在标准临床环境中评估MS进展相关病理提供了可行的成像参数。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.80
自引率
20.00%
发文量
814
审稿时长
66 days
期刊介绍: Multiple Sclerosis is an area of ever expanding research and escalating publications. Multiple Sclerosis and Related Disorders is a wide ranging international journal supported by key researchers from all neuroscience domains that focus on MS and associated disease of the central nervous system. The primary aim of this new journal is the rapid publication of high quality original research in the field. Important secondary aims will be timely updates and editorials on important scientific and clinical care advances, controversies in the field, and invited opinion articles from current thought leaders on topical issues. One section of the journal will focus on teaching, written to enhance the practice of community and academic neurologists involved in the care of MS patients. Summaries of key articles written for a lay audience will be provided as an on-line resource. A team of four chief editors is supported by leading section editors who will commission and appraise original and review articles concerning: clinical neurology, neuroimaging, neuropathology, neuroepidemiology, therapeutics, genetics / transcriptomics, experimental models, neuroimmunology, biomarkers, neuropsychology, neurorehabilitation, measurement scales, teaching, neuroethics and lay communication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书